U.S. Specialty Stores Stock News

New Fortress Energy (NFE) closed out FY 2025 with Q4 revenue of US$415.9 million and a basic EPS loss of US$2.77, alongside a net income loss of US$788.4 million. Over the last six reported quarters, revenue has ranged from US$301.7 million to US$668.2 million, while basic EPS has swung between a small profit of US$0.03 and a loss of US$2.77. This gives investors a wide view of how top line scale and per share losses have moved together. With trailing 12 month revenue at about US$1.5 billion...

EnerSys (ENS) is drawing fresh investor attention after expanding into AI focused data centers and electric vehicle charging, while also tapping U.S. tax incentives to support domestic manufacturing and its broader stored energy portfolio. See our latest analysis for EnerSys. The recent expansion into AI focused data centers and EV charging seems to be resonating with the market, with a 30 day share price return of 23.57% contributing to a 1 year total shareholder return of 140.09%. This...

In recent days, Doximity has been in focus as investors, analysts, and fund managers reassessed the company’s prospects amid new AI innovations and insider Form 144 stock sale filings tied to option exercises. What stands out is that, even as AI tools like Anthropic’s Managed Agents spark concern about disruption to traditional SaaS models, several investors still frame Doximity as a potential long-term beneficiary of AI given its physician-centric platform and existing AI product...

If you are wondering whether Dyne Therapeutics at around US$19.81 is still offering value or has already priced in much of the story, the next sections aim to put the current share price in context. The stock has recently posted returns of 9.1% over 7 days, 10.5% over 30 days, 7.1% year to date and 152.4% over the past year, which can change how investors see both its potential and its risks. Recent news flow around Dyne Therapeutics has centered on its progress as a biotechnology name and...

If you are wondering whether Sanmina's current share price offers value or signals that you may be late to the story, it helps to step back and look at what the recent returns are really telling you. The stock recently closed at US$154.47, with returns of 17.2% over 7 days, 23.4% over 30 days, a 3.0% decline year to date, and 101.8% over the past year, alongside 176.8% over 3 years and 274.6% over 5 years. Recent price moves sit against a backdrop of ongoing investor interest in electronics...

Bloom Energy (NYSE:BE) announced an expanded partnership with Oracle to deliver up to 2.8GW of fuel cell capacity for AI and cloud data centers. The agreement marks the largest single customer order in Bloom Energy's history, with initial deployment already underway. The projects are focused on supporting Oracle's U.S. AI data center buildout and related power needs. Bloom Energy, which provides fuel cell based power solutions, is moving deeper into the data center power segment as AI and...

Why ASP Isotopes (ASPI) Is Drawing Attention After Its Latest Earnings ASP Isotopes (ASPI) is back on investors’ radar after its full year 2025 earnings report, which paired US$23.85 million of revenue with a net loss of US$175.09 million, along with a follow up business update call. See our latest analysis for ASP Isotopes. The share price now sits at US$5.00, with a 7 day share price return of 22.85% contrasting with a 90 day share price return decline of 29.48%. The 3 year total...

In early April 2026, iQIYI announced plans for iQIYI LAND in Wuhan’s Hanyangzao Cultural and Creative Industry Park, its first urban renewal–integrated theme park and fourth immersive IP-based park nationwide, while also launching Nadou Pro, an AI agent designed to support end-to-end professional film and TV production workflows. Together, the Wuhan park development and Nadou Pro launch underline how iQIYI is extending its content IP beyond streaming, into both offline experiential venues...

If you are wondering whether Star Bulk Carriers is priced attractively or already reflects its potential, this article breaks down what the current share price could mean for you as an investor. At a last close of US$24.73, the stock has returns of 2.6% over 7 days, 13.2% over 30 days, 27.7% year to date and 78.8% over 1 year. These recent moves are front of mind when thinking about value and risk. Recent coverage has focused on Star Bulk Carriers within the broader shipping sector,...

A law firm has launched an investigation and class action complaint targeting e.l.f. Beauty (NYSE:ELF) and its board of directors. The complaint alleges false and misleading statements related to revenue reporting and inventory disclosures. The case raises questions about the company’s financial reporting practices and board oversight. For investors tracking NYSE:ELF, this legal action comes at a time when the stock trades around $65.62, with a mixed return profile. Shares are up 3.8% over...

A10 Networks has recently reported its fourth quarter and full year 2024 results, showing modest revenue growth and highlighting progress across both service provider and enterprise customers. The company is leaning into new security and AI-focused offerings, including bot protection, DDoS mitigation, and solutions tailored for GPU-based AI infrastructure, which management positions as key future growth drivers. We’ll now examine how these emerging AI and security product initiatives may...

If you are wondering whether Enovis is priced attractively right now, the recent share performance and valuation checks offer some clear signals to unpack. The stock last closed at US$24.86, with returns of 9.2% over 7 days and 8.1% over 30 days, while year to date it is down 6.2%, and the 1 year return sits at a 23.1% decline, extending a 55.3% decline over 3 years and 67.8% over 5 years. These moves sit against a backdrop where investors have been reassessing Enovis within the Medical...

Citigroup (NYSE:C) reported its strongest quarterly results in a decade in Q1 2026, with net income up 42% year over year. The bank delivered record revenue in its markets segment, supported by double digit gains in both trading and investment banking. Wealth management revenue also showed significant growth, contributing to overall earnings strength. Citigroup reported substantial progress on its transformation plan, including asset divestitures and share repurchases. For investors...

Wondering if AAR is still reasonably priced after a strong run, or if you might be arriving late to the story? This article walks through what the current share price could mean for you. At a last close of US$123.77, AAR has returns of 8.6% over 7 days, 21.5% over 30 days, 46.6% year to date, 128.3% over 1 year, 127.8% over 3 years and 211.1% over 5 years. This naturally raises questions about what is already reflected in the price. The recent moves sit against a backdrop of ongoing interest...

Viatris (NasdaqGS:VTRS) is presenting four Phase 3 ophthalmic clinical study abstracts at the 2026 ASCRS Annual Meeting. The data include new findings in presbyopia and visual disturbance treatments using phentolamine ophthalmic solutions. These late stage results may be important for Viatris' ophthalmology portfolio and potential future product approvals. For investors tracking NasdaqGS:VTRS at a share price of $13.83, this spotlight on Phase 3 ophthalmic data comes on top of a share price...

In early April 2026, Alnylam Pharmaceuticals highlighted new clinical data for its ATTR-CM therapy vutrisiran at the American College of Cardiology meeting, while also marking free cash flow breakeven in 2025 and continued recognition for its RNAi-based cardiovascular portfolio. Investor interest was further underlined as a large-cap growth fund added Alnylam to its portfolio, aligning institutional conviction with improving financial footing and reinforcing attention on the company’s...

NextDecade Corporation recently announced it will host a conference call and webcast on May 1, 2026, to review its first-quarter 2026 developments, accompanied by a press release and presentation on its website. This update comes as the company’s liquefied natural gas and carbon capture ambitions intersect with weaker sector sentiment following a US-Iran ceasefire that pressured natural gas prices. Against this backdrop, we will examine how shifting energy-sector sentiment tied to the...

Bread Financial Holdings (BFH) is back in focus after rising optimism around its upcoming earnings report, recent earnings beats, a new passive stake from Dimensional Fund Advisors, and fresh media attention on its branded credit card niche. See our latest analysis for Bread Financial Holdings. At a share price of US$80.19, Bread Financial has seen strong momentum recently, with a 30 day share price return of 12.11% and a 1 year total shareholder return of 80.89%, while the 3 year total...

If you are wondering whether Kenvue's current share price offers value or just more volatility, looking closely at what you are paying for each dollar of the business becomes crucial. The stock recently closed at US$17.26, with returns of a 0.2% decline over 7 days, a 1.3% decline over 30 days, a 0.3% decline year to date, and a 20.7% decline over the past year, which may change how investors think about both its potential and its risks. Recent headlines around Kenvue have focused on how it...

Several major brokerages recently lifted their views on Celanese (CE), citing growing optimism around earnings and potential growth across core end markets. This has brought fresh attention to the stock’s recent performance. See our latest analysis for Celanese. The recent broker upgrades have come alongside strong momentum in Celanese’s share price, with a 48.69% 3 month share price return, a 61.81% year to date share price return, and a 74.50% 1 year total shareholder return, contrasting...

Wondering whether Silgan Holdings at around US$41.87 is priced for opportunity or caution? This article breaks down what the current share price could be implying about value. The stock is up 6.1% over the last 7 days and 0.6% over the past month, yet year to date it is only up 1.5%, and the 1 year return sits at a 14.0% decline. That mix of recent gains and a weaker 1 year and 3 year record, with returns of a 14.0% decline and 16.2% decline respectively, has kept Silgan on the radar for...

If you are wondering whether AllianceBernstein Holding at around US$38.67 is still fairly priced or starting to look interesting, you are not alone. The stock's recent returns, including 1.4% over the past week, 1.5% over the past month, 0.1% year to date, 11.3% over the past year, 36.5% over three years, and 47.0% over five years, provide a useful backdrop for thinking about value and risk today. Recent coverage has focused on AllianceBernstein Holding's role in the capital markets sector...

Charles Schwab (SCHW) is facing a mix of headwinds after several firms softened their outlook on the brokerage and a FINRA ruling raised compliance questions, just as AI driven competitors began pressuring wealth management fees. See our latest analysis for Charles Schwab. Despite recent regulatory headlines, analyst downgrades and concerns over AI driven fee pressure, the current US$96.79 share price comes after a 7 day share price return of 4.09%, alongside a 1 year total shareholder return...

Moody’s shifted its outlook on Blue Owl Credit Income Corp., a key private credit vehicle for Blue Owl Capital (NYSE:OWL), to negative, citing higher than peer redemption requests. Investor redemption pressures are building across parts of Blue Owl’s private credit platform, raising questions about liquidity management and funding flexibility. A pending investor lawsuit alleges undisclosed liquidity challenges linked to asset base pressures from business development company redemptions. For...